US Patent 8865729 Salt forms of a xanthine compound

Patent 8865729 was granted and assigned to Boehringer Ingelheim on October, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Boehringer Ingelheim

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88657290

Patent Inventor Names

Peter Sieger0

Waldemar Pfrengle0

Date of Patent

October 21, 2014

Patent Application Number

131408530

Date Filed

December 22, 2009

Patent Citations Received

‌

US Patent 11911388 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

‌

US Patent 11919903 Polymorphs

‌

US Patent 11911387 Vasoprotective and cardioprotective antidiabetic therapy

Patent Primary Examiner

‌

Jeffrey H Murray

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8865729 Salt forms of a xanthine compound

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API